Patents by Inventor Bruno Domon

Bruno Domon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PANCREATIC CANCER TARGETS AND USES THEREOF
    Publication number: 20150132286
    Abstract: The present invention provides a method for diagnosing and detecting diseases associated with pancreas. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in pancreatic diseases (PCAT) and antibodies binds to PCAT. The present invention provides that PCAT is used as targets for screening agents that modulates the PCAT activities. Further, the present invention provides methods for treating diseases associated with pancreas.
    Type: Application
    Filed: September 18, 2014
    Publication date: May 14, 2015
    Inventors: Bruno DOMON, Ian MCCAFFREY, Vaibhav NARAYAN, Scott PATTERSON
  • Analyte mass spectrometry quantitation using a universal reporter
    Patent number: 8933396
    Abstract: Quantitation of analytes, including but not limited to peptides, polypeptides, and proteins, in mass spectrometry using a labeled peptide coupled to a reporter, and a universal reporter.
    Type: Grant
    Filed: July 7, 2011
    Date of Patent: January 13, 2015
    Assignee: Thermo Fisher Scientific GmbH
    Inventors: Joel Louette, John Charles Rogers, Scott M. Peterman, Bruno Domon, Elodie Duriez
  • METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING DISEASES
    Publication number: 20140314768
    Abstract: Methods and compositions for diagnosing and treating diseases, particularly cancer, associated with differential expression of cancer-associated targets (CAT) in disease cells compared to healthy cells are provided. Also provided are antagonists and agonists of CAT, and methods for screening agents that modulate CAT level or activity in vivo or in vitro.
    Type: Application
    Filed: December 6, 2013
    Publication date: October 23, 2014
    Applicant: CELERA CORPORATION
    Inventors: Steve RUBEN, Karen VAN ORDEN, Bruno DOMON, Candy LEE, Tao HE, Mehdi MESRI, Elizabeth JOSELOFF, Katherine MCKINNON, Paul MOORE, Charles BIRSE
  • Pancreatic cancer targets and uses thereof
    Patent number: 8865413
    Abstract: The present invention provides a method for diagnosing and detecting diseases associated with pancreas. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in pancreatic diseases (PCAT) and antibodies binds to PCAT. The present invention provides that PCAT is used as targets for screening agents that modulates the PCAT activities. Further, the present invention provides methods for treating diseases associated with pancreas.
    Type: Grant
    Filed: May 4, 2011
    Date of Patent: October 21, 2014
    Assignee: Celera Corporation
    Inventors: Bruno Domon, Ian McCaffery, Vaibhav Narayan, Scott Patterson
  • METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING DISEASES
    Publication number: 20140193419
    Abstract: Methods and compositions for diagnosing and treating diseases, particularly cancer, associated with differential expression of cancer-associated targets (CAT) in disease cells compared to healthy cells are provided. Also provided are antagonists and agonists of CAT, and methods for screening agents that modulate CAT level or activity in vivo or in vitro.
    Type: Application
    Filed: December 6, 2013
    Publication date: July 10, 2014
    Applicant: CELERA CORPORATION
    Inventors: Steve RUBEN, Karen VAN ORDEN, Bruno DOMON, Candy LEE, Tao HE, Mehdi MESRI, Elizabeth JOSELOFF, Katherine MCKINNON, Paul MOORE, Charles BIRSE
  • METHODS AND COMPOSITIONS FOR TREATING DISEASES TARGETING MABA
    Publication number: 20140178362
    Abstract: Methods and compositions for detecting and treating a disease, particularly cancer, associated with differential expression of Maba in disease cells compared to healthy cells. Also provided are antagonists or agonists of Maba, and methods for screening agents that modulate the Maba level or activity in vivo or in vitro.
    Type: Application
    Filed: July 1, 2013
    Publication date: June 26, 2014
    Applicant: CELERA CORPORATION
    Inventors: Charles E. BIRSE, Bruno DOMON, Steve RUBEN, Candy LEE
  • COLON DISEASE TARGETS AND USES THEREOF
    Publication number: 20140178391
    Abstract: The present invention provides a method for diagnosing and detecting diseases associated with colon. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in colon diseases (CCAT) and antibodies binds to CCAT. The present invention provides that CCAT is used as targets for screening agents that modulates the CCAT activities. Further the present invention provides methods for treating diseases associated with colon.
    Type: Application
    Filed: October 18, 2013
    Publication date: June 26, 2014
    Applicant: Celera Corporation
    Inventors: Bruno DOMON, Aiqun LI, Tao HE, Ian MCCAFFREY
  • Methods and compositions for treating and diagnosing diseases
    Patent number: 8632987
    Abstract: Methods and compositions for diagnosing and treating diseases, particularly cancer, associated with differential expression of cancer-associated targets (CAT) in disease cells compared to healthy cells are provided. Also provided are antagonists and agonists of CAT, and methods for screening agents that modulate CAT level or activity in vivo or in vitro.
    Type: Grant
    Filed: November 6, 2012
    Date of Patent: January 21, 2014
    Assignee: Celera Corporation
    Inventors: Steve Ruben, Bruno Domon, Candy Lee
  • Methods and compositions for treating diseases targeting maba
    Patent number: 8507213
    Abstract: Methods and compositions for detecting and treating a disease, particularly cancer, associated with differential expression of Maba in disease cells compared to healthy cells. Also provided are antagonists or agonists of Maba, and methods for screening agents that modulate the Maba level or activity in vivo or in vitro.
    Type: Grant
    Filed: November 8, 2006
    Date of Patent: August 13, 2013
    Assignee: Celera Corporation
    Inventors: Candy Lee, Steve Ruben, Bruno Domon, Charles E. Birse
  • ANALYTE MASS SPECTROMETRY QUANTITATION USING A UNIVERSAL REPORTER
    Publication number: 20130105684
    Abstract: Quantitation of analytes, including but not limited to peptides, polypeptides, and proteins, in mass spectrometry using a labeled peptide coupled to a reporter, and a universal reporter.
    Type: Application
    Filed: July 7, 2011
    Publication date: May 2, 2013
    Inventors: Joel Louette, John Charles Rogers, Scott M. Peterman, Bruno Domon, Elodie Duriez
  • COLON CANCER TARGETS AND USES THEREOF
    Publication number: 20130067608
    Abstract: The present invention provides a method for diagnosing and detecting diseases associated with colon. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in colon diseases (CCAT) and antibodies binds to CCAT. The present invention provides that CCAT is used as targets for screening agents that modulates the CCAT activities. Further the present invention provides methods for treating diseases associated with colon.
    Type: Application
    Filed: August 16, 2012
    Publication date: March 14, 2013
    Applicant: CELERA CORPORATION
    Inventors: Bruno DOMON, Aiqun LI, Tao HE, Ian MCCAFFERY
  • Methods and compositions for treating and diagnosing diseases
    Patent number: 8334106
    Abstract: Methods and compositions for diagnosing and treating diseases, particularly cancer, associated with differential expression of cancer-associated targets (CAT) in disease cells compared to healthy cells are provided. Also provided are antagonists and agonists of CAT, and methods for screening agents that modulate CAT level or activity in vivo or in vitro.
    Type: Grant
    Filed: December 29, 2011
    Date of Patent: December 18, 2012
    Assignee: Celera Corporation
    Inventors: Steve Ruben, Candy N. Lee, Bruno Domon
  • METHODS AND COMPOSITIONS FOR TREATING AND DIAGNOSING DISEASES
    Publication number: 20120177659
    Abstract: Methods and compositions for diagnosing and treating diseases, particularly cancer, associated with differential expression of cancer-associated targets (CAT) in disease cells compared to healthy cells are provided. Also provided are antagonists and agonists of CAT, and methods for screening agents that modulate CAT level or activity in vivo or in vitro.
    Type: Application
    Filed: December 29, 2011
    Publication date: July 12, 2012
    Applicant: CELERA CORPORATION
    Inventors: Steve RUBEN, Karen VAN ORDEN, Candy N. LEE, Tao HE, Mehdi MESRI, Elizabeth G. JOSELOFF, Paul MOORE, Katherine MCKINNON, Bruno DOMON
  • PANCREATIC CANCER TARGETS AND USES THEREOF
    Publication number: 20120128677
    Abstract: The present invention provides a method for diagnosing and detecting diseases associated with pancreas. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in pancreatic diseases (PCAT) and antibodies binds to PCAT. The present invention provides that PCAT is used as targets for screening agents that modulates the PCAT activities. Further, the present invention provides methods for treating diseases associated with pancreas.
    Type: Application
    Filed: May 4, 2011
    Publication date: May 24, 2012
    Applicant: CELERA CORPORATION
    Inventors: Bruno DOMON, Ian MCCAFFERY, Vaibhav NARAYAN, Scott PATTERSON
  • Methods and compositions for treating and diagnosing diseases
    Patent number: 8110373
    Abstract: Methods and compositions for diagnosing and treating diseases, particularly cancer, associated with differential expression of cancer-associated targets (CAT) in disease cells compared to healthy cells are provided. Also provided are antagonists and agonists of CAT, and methods for screening agents that modulate CAT level or activity in vivo or in vitro.
    Type: Grant
    Filed: July 17, 2009
    Date of Patent: February 7, 2012
    Assignee: Celera Corporation
    Inventors: Steve Ruben, Candy N. Lee, Bruno Domon
  • COLON CANCER TARGETS AND USES THEREOF
    Publication number: 20110296544
    Abstract: The present invention provides a method for diagnosing and detecting diseases associated with colon. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in colon diseases (CCAT) and antibodies binds to CCAT. The present invention provides that CCAT is used as targets for screening agents that modulates the CCAT activities. Further the present invention provides methods for treating diseases associated with colon.
    Type: Application
    Filed: May 16, 2011
    Publication date: December 1, 2011
    Applicant: CELERA CORPORATION
    Inventors: Bruno DOMON, Alqun Li, Tao He, Ian McCaffery
  • LUNG DISEASE TARGETS AND USES THEREOF
    Publication number: 20110219464
    Abstract: The present invention provides a method for diagnosing and detecting diseases associated with lung. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in lung cancer (LCAT) and antibodies binds to LCATs. The present invention provides that LCATs are used as targets for screening agents that modulates the LCAT activities. Further the present invention provides methods for treating diseases associated with lung.
    Type: Application
    Filed: August 25, 2010
    Publication date: September 8, 2011
    Applicant: CELERA CORPORATION
    Inventors: Bruno DOMON, Elizabeth JOSELOFF, Aiqun LI, Tao HE
  • Colon cancer targets and uses thereof
    Patent number: 7960100
    Abstract: The present invention provides a method for diagnosing and detecting diseases associated with colon. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in colon diseases (CCAT) and antibodies binds to CCAT. The present invention provides that CCAT is used as targets for screening agents that modulates the CCAT activities. Further the present invention provides methods for treating diseases associated with colon.
    Type: Grant
    Filed: March 17, 2008
    Date of Patent: June 14, 2011
    Assignee: Celera Corporation
    Inventors: Bruno Domon, Aiqun Li, Tao He, Ian McCaffery
  • Lung disease targets and uses thereof
    Patent number: 7807392
    Abstract: The present invention provides a method for diagnosing and detecting diseases associated with lung. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in lung cancer (LCAT) and antibodies binds to LCATs. The present invention provides that LCATs are used as targets for screening agents that modulates the LCAT activities. Further the present invention provides methods for treating diseases associated with lung.
    Type: Grant
    Filed: September 28, 2007
    Date of Patent: October 5, 2010
    Assignee: Celera Corporation
    Inventors: Bruno Domon, Elizabeth Joseloff, Aiqun Li, Tao He
  • Colon disease targets and uses thereof
    Patent number: 7776555
    Abstract: The present invention provides a method for diagnosing and detecting diseases associated with colon. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in colon diseases (CCAT) and antibodies binds to CCAT. The present invention provides that CCAT is used as targets for screening agents that modulates the CCAT activities. Further the present invention provides methods for treating diseases associated with colon.
    Type: Grant
    Filed: July 2, 2007
    Date of Patent: August 17, 2010
    Assignee: Celera Corporation
    Inventors: Bruno Domon, Steve Ruben, Charles E. Birse, Yeoun Jin Kim, Tao He, Ian McCaffery